Biofrontera Inc.(NASDAQ:BFRI) 
Biofrontera Inc., a biopharmaceutical company, develops and provides dermatological products for the treatment of skin diseases in the United States. It primarily develops therapies for non-melanoma skin cancer. It offers Ameluz, an aminolevulinic acid hydrochloride gel for the photodynamic therapy ...
Website: http://www.biofrontera.us.com
Founded: 1997
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.73
H 0.75
L 0.68
C 0.74
V 70,138
10EMA 0.74
20EMA 0.74
60EMA 0.74
120EMA 0.74
250EMA 0.74